These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26707452)

  • 1. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
    Jang D; Lee S; Lee J; Kim K; Lee D
    J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PISTON: Predicting drug indications and side effects using topic modeling and natural language processing.
    Jang G; Lee T; Hwang S; Park C; Ahn J; Seo S; Hwang Y; Yoon Y
    J Biomed Inform; 2018 Nov; 87():96-107. PubMed ID: 30268842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of drug indications based on chemical interactions and chemical similarities.
    Huang G; Lu Y; Lu C; Zheng M; Cai YD
    Biomed Res Int; 2015; 2015():584546. PubMed ID: 25821813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
    Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
    BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records.
    Paik H; Chung AY; Park HC; Park RW; Suk K; Kim J; Kim H; Lee K; Butte AJ
    Sci Rep; 2015 Mar; 5():8580. PubMed ID: 25739475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Literature-based prediction of novel drug indications considering relationships between entities.
    Jang G; Lee T; Lee BM; Yoon Y
    Mol Biosyst; 2017 Jun; 13(7):1399-1405. PubMed ID: 28581007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity.
    Yu L; Zhao J; Gao L
    Int J Biol Sci; 2018; 14(8):971-982. PubMed ID: 29989066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DrPOCS: Drug Repositioning Based on Projection Onto Convex Sets.
    Wang YY; Cui C; Qi L; Yan H; Zhao XM
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(1):154-162. PubMed ID: 29993698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: Where a recommendation system meets genome-wide association studies.
    Wang H; Gu Q; Wei J; Cao Z; Liu Q
    Clin Pharmacol Ther; 2015 May; 97(5):451-4. PubMed ID: 25670647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
    Jadamba E; Shin M
    Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
    Yang CC; Zhao M
    Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
    Iwata H; Sawada R; Mizutani S; Yamanishi Y
    J Chem Inf Model; 2015 Feb; 55(2):446-59. PubMed ID: 25602292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repurposing by integrated literature mining and drug-gene-disease triangulation.
    Sun P; Guo J; Winnenburg R; Baumbach J
    Drug Discov Today; 2017 Apr; 22(4):615-619. PubMed ID: 27780789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network mirroring for drug repositioning.
    Park S; Lee DG; Shin H
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target-Based Drug Repositioning Using Large-Scale Chemical-Protein Interactome Data.
    Sawada R; Iwata H; Mizutani S; Yamanishi Y
    J Chem Inf Model; 2015 Dec; 55(12):2717-30. PubMed ID: 26580494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of drug gene associations via ontological profile similarity with application to drug repositioning.
    Kissa M; Tsatsaronis G; Schroeder M
    Methods; 2015 Mar; 74():71-82. PubMed ID: 25498216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Drug Repositioning Approach Based on Collaborative Metric Learning.
    Luo H; Wang J; Yan C; Li M; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):463-471. PubMed ID: 31283509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based inference methods for drug repositioning.
    Chen H; Zhang H; Zhang Z; Cao Y; Tang W
    Comput Math Methods Med; 2015; 2015():130620. PubMed ID: 25969690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space.
    Dai W; Liu X; Gao Y; Chen L; Song J; Chen D; Gao K; Jiang Y; Yang Y; Chen J; Lu P
    Comput Math Methods Med; 2015; 2015():275045. PubMed ID: 26078775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repositioning for diabetes based on 'omics' data mining.
    Zhang M; Luo H; Xi Z; Rogaeva E
    PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.